Spigset O - Search Results

1

Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction - a prospective observational study.

Anstensrud AK, Molden E, Haug HJ, Qazi R, Muriq H, Fosshaug LE, Spigset O, Øie E. Anstensrud AK, et al. Among authors: spigset o. Eur J Clin Pharmacol. 2020 May;76(5):673-683. doi: 10.1007/s00228-020-02832-0. Epub 2020 Jan 15. Eur J Clin Pharmacol. 2020. PMID: 31940084

2

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms.

Spigset O, Granberg K, Hägg S, Norström A, Dahlqvist R. Spigset O, et al. Eur J Clin Pharmacol. 1997;52(2):129-33. doi: 10.1007/s002280050261. Eur J Clin Pharmacol. 1997. PMID: 9174682

3

Non-linear fluvoxamine disposition.

Spigset O, Granberg K, Hägg S, Söderström E, Dahlqvist R. Spigset O, et al. Br J Clin Pharmacol. 1998 Mar;45(3):257-63. doi: 10.1046/j.1365-2125.1998.00670.x. Br J Clin Pharmacol. 1998. PMID: 9517369 Free PMC article. Clinical Trial.

4

Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.

Hägg S, Spigset O, Lakso HA, Dahlqvist R. Hägg S, et al. Among authors: spigset o. Eur J Clin Pharmacol. 2001 Sep;57(6-7):493-7. doi: 10.1007/s002280100343. Eur J Clin Pharmacol. 2001. PMID: 11699614 Clinical Trial.

5

The major fluvoxamine metabolite in urine is formed by CYP2D6.

Spigset O, Axelsson S, Norström A, Hägg S, Dahlqvist R. Spigset O, et al. Eur J Clin Pharmacol. 2001 Nov;57(9):653-8. doi: 10.1007/s002280100373. Eur J Clin Pharmacol. 2001. PMID: 11791895

6

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.

Güzey C, Scordo MG, Spina E, Landsem VM, Spigset O. Güzey C, et al. Among authors: spigset o. Eur J Clin Pharmacol. 2007 Mar;63(3):233-41. doi: 10.1007/s00228-006-0234-8. Epub 2007 Jan 17. Eur J Clin Pharmacol. 2007. PMID: 17225991

7

[Fruit and berries--interactions with drugs].

Molden E, Spigset O. Molden E, et al. Among authors: spigset o. Tidsskr Nor Laegeforen. 2007 Dec 13;127(24):3218-20. Tidsskr Nor Laegeforen. 2007. PMID: 18084364 Free article. Norwegian.

8

[Cytochrome P-450 3A4--the most important arena for drug interactions in the body].

Spigset O, Molden E. Spigset O, et al. Tidsskr Nor Laegeforen. 2008 Dec 18;128(24):2832-5. Tidsskr Nor Laegeforen. 2008. PMID: 19092951 Free article. Review. Norwegian.

9

[Tobacco smoking and drug interactions].

Molden E, Spigset O. Molden E, et al. Among authors: spigset o. Tidsskr Nor Laegeforen. 2009 Mar 26;129(7):632-3. doi: 10.4045/tidsskr.08.0122. Tidsskr Nor Laegeforen. 2009. PMID: 19337332 Free article. Norwegian.

10

Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly.

Vandraas KF, Spigset O, Mahic M, Slørdal L. Vandraas KF, et al. Among authors: spigset o. Eur J Clin Pharmacol. 2010 Aug;66(8):823-9. doi: 10.1007/s00228-010-0825-2. Epub 2010 Apr 20. Eur J Clin Pharmacol. 2010. PMID: 20405110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters